Interestingly, a recent high-throughput screen on 313 kinase-deficient cell lines revealed that DYRK4 knockout cells were among the most sensitive to agents that produce DNA damage [168], suggesting that DYRK4 might merit further exploration as a putative target to enhance chemotherapy toxicity on cancer cells. The gene discussed is DYRK4; the disease is cancer.